Table 1 Patient demographics
4-Fr vascular sheath size population | 6-Fr vascular sheath size population | |
|---|---|---|
No. of procedures | 168 | 152 |
No. of patients | 164 | 150 |
Age – mean (range) years | 61.7 (21–92) | 69.7 (21–94) |
Sex M:F | 71:93 | 115:35 |
Hypertension | 52 (32.7%) – 5 unavailable | 74 (50.3%) – 3 unavailable |
Diabetes | 47 (28.8%) – 1 unavailable | 49 (33.3%) – 3 unavailable |
Anticoagulation | 3 unavailable | 2 unavailable |
Nil | 93 (57.8%) | 76 (51.4%) |
Warfarin | 3 (1.9%) | 1 (0.7%) |
Aspirin | 25 (15.5%) | 18 (12.2%) |
Clopidogrel | 5 (3.1%) | 3 (2%) |
Treatment dose heparin | 3 (1.9%) | 4 (2.7%) |
Prophylactic dose low molecular weight heparin | 19 (11.8%) | 23 (15.5%) |
Multiple | 13 (8.1%) | 23 (15.5%) |
INR | 1 unavailable | 2 unavailable |
< 1.5 | 160 (98.1%) | 144 (97.3%) |
> 1.5 | 3 (1.9%) | 4 (2.7%) |
Platelets (109/L) | 1 unavailable | 3 unavailable |
< 50 | 1 (0.6%) | 1 (0.7%) |
> 50, < 100 | 4 (2.5%) | 4 (2.7%) |
> 100 | 158 (96.9%) | 142 (96.6%) |